Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.6B | 2.7B | 3.5B | 3.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 867M | 770M | 832M | 810M |
| Other operating expenses | 416M | 377M | 406M | 396M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 61M | 60M | 57M | 56M |
| Other income expense | — | — | — | — |
| Pretax income | 382M | 111M | 640M | 313M |
| Tax provision | 98M | 29M | 144M | 44M |
| Net income | 293M | 83M | 508M | 271M |
| Basic EPS | 1.0 | 0.3 | 1.7 | 1.0 |
| Diluted EPS | 1.0 | 0.3 | 1.7 | 1.0 |
| Basic average shares | 272M | 273M | 272M | 272M |
| Diluted average shares | 273M | 273M | 273M | 273M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 293M | 83M | 508M | 271M |
| Minority interests | -15M | 0 | -58M | -5M |
| Preferred stock dividends | — | — | — | — |